Measure of maternal procalcitonin in the pregnancy by an ultrasensitive immunoluminometric assay: Diagnostic and pronostic interests;Dosage de la procalcitonine maternelle au cours de la grossesse par une méthode immunoluminométrique ultrasensible: Intérêts diagnostique et pronostique

Immuno-Analyse et Biologie Specialisee

Volumn 18, Issue 5, 2003, Pages 256-259

  Chaker, S ^a   Gnat, D ^a   Ben Ali, N ^a   Hansen, V ^a   Barlow, P ^a   Haumont, D ^a   Vertongen, F ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

F tomaternal infection; Normal values; PCT; Pregnancy

Indexed keywords

PROCALCITONIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GESTATIONAL AGE; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; IMMUNOLUMINOMETRIC ASSAY; NORMAL HUMAN; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; STUDENT T TEST;

EID: 1042289496     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(03)00079-6     Document Type: Article

References (27)

1. Assumma M., Signore F., Pacifico L., Rossi N., Osborn J.F., Chiesa C. Serum Procalcitonin Concentration in Term Delivering Mothers and Their Healty Offspring: A Longitudinal Study. Clinical Chemistry. 46:2000;1583-1587.
2. Austgulen R., Lien E., Liabakk G., Jacobsen G., Arntzen K.J. Increased level of cytokine activity modifiers in normal pregnancy. Eur J Obstet Reprod Biol. 57:(3):1994 Dec;149-155.
3. Carroll S.G., Papaioannou S., Davies E.T., Nicalaides K.H. Maternal assessment in the prediction of intra-uterine infection in preterm prelabor amniorrhexis. Fetal Diagn Ther. 10:(5):1995;290-296.
4. Chiesa C., Panero A., Rossi N., Stegagno M., De Giusti M., Osborn J.-F., et al. Reliability of Procalcitonin concentrations for the Diagnosis of Sepsis in Critically III Neanates. Clinical Infectious Diseases. 26:1998;664-672.
5. Chiesa C., Pellegrini G., Panero A., Osborn J., Signore F., Assumma M., et al. C-reactive Protein, Interleukin-6, and Procalcitonin in the Immediate Postnatal Period: Influence of Illness Severity, Risk Status, Antenatal and Perinatal Complications, and Infection. Clinical Chemistry. 49:(1):2003;60-68.
6. Dandona P., Nix D., Wilson M., Aljada A., Love J., Assicot M., et al. Procalcitonin Increase after Endotoxin Injection in Normal Subjects. Journal of Clinical Endocrinology and metabolism. Vol. 79:(No. 5):1994;1605-1608.
7. Ferrière F. Intérêt de la procalcitonine, nouveau marqueur de l'infection bactérienne. Ann Biol Clin. 58:2000;49-59.
8. Gendrel D., Assicot M., Raymond J., Moulin F., Francoual C., Badoual J., et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. The Journal of Pediatrics. Vol. 128:(No. 4):1996;570-573.
9. Gendrel D., Raymond J., Coste J., Moulin F., Lorrot M., Guerin S., et al. Comparaison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J. 18:1999;875-881.
10. Gendrel D., Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr infect Dis J. 19:2000;679-688.
11. Gibbs R.S., Romero R., Hillier S.L., Eschenbach D.A., Sweet R.L. A review of premature birth and subclinical infection. Am J Obstet Gynycol. 1999;1515-1528.
12. o1):2001;153-163.
13. Hatherill M., Tibby S., Sykes K., Turner C., Murdoch I. Diagnostic markers of infection: comparaison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child. 81:1999;417-421.
14. Janota J., Stranak Z., Belohlavkova S., Mudra K., Simak J. Postnatal increase of procalcitonin in premature newborns is enhanced by chorio-amniotis and neonatal sepsis. Eur J Clin Invest. 31:(11):2001;978-983.
15. Jobe A. et Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respiratory Research 2001;Vol. 2 No 1: 27-32.
16. o5):2001;295-304.
17. McDonald H.M., Chambers H.M. Intra-uterine infection and spontaneous midgestation abortion: is the spectrum of micro-organisms similar to that in preterm labor? Infect Dis Obstet Gynecol. 8:(5-6):2000;220-227.
18. Meisner M., Tschaikowsky K., Schnabel S., Schmidt J., Katalinic A., Schuttler J. Procalcitonin- Influence of Temperarure, Storage, Anticoagulation and Arterial or Venous Asservation of Blood Samples on Procalcitonin Concentrations. Eur J Clin Chem Clin Biochem. 35:(8):1997;597-601.
19. Morgenthaler N.G., Struck J., Fischer-Schulz C., Seidel-mueller E., Beier W., Bergmann A. Detection of Procalcitonin (PCT) in Healty Controls and Patients with Local Infection by a Sensitive ILMA. Clin Lab. 48:2002;263-270.
20. o4):2000;977-983.
21. o2):2000;458-461.
22. Oberhoffer M., Vogelsang H., Rubwurm S., Hartung T., Reinhart K. Outcome Prediction by Traditionnal and New Markers of Inflammation in Patients with Sepsis. Clin Chem Lab M. 37:(3):1999;363-368.
23. Petzold L., Guibourdenche J., Boissinot C., Benoist J.-F., Luton D., Demelier J.-F., et al. Apport de la procalcitonine dans le diagnostic des infections maternofœtales. Ann Biol Clin. 56:1998;599-602.
24. Reinart K., Karzai W., Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care M. 26:2000;1193-1200.
25. Saito S. Cytokine cross-talk between mother and the embryo/placenta. Journal of Reproductive Immunology. 52:2001;15-33.
26. Schroder J., Staubach K.-H., Zabel P., Stuber F., Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbeck's Arch Surg. 384:1999;33-38.
27. Whicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 38:2001;483-493.